Published in Nihon Rinsho on November 01, 2002
Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005. J Clin Microbiol (2007) 1.45
Regression of liver fibrosis in cases of chronic liver disease type C: quantitative evaluation by using computed image analysis. Intern Med (2004) 1.44
Long-term macrolide antibiotic therapy in the treatment of chronic small airway disease clinically mimicking diffuse panbronchiolitis. Intern Med (2005) 1.41
Relation of Helicobacter pylori infection to plasma vitamin B12, folic acid, and homocysteine levels in patients who underwent diagnostic coronary arteriography. Am J Gastroenterol (2002) 1.11
Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med (2004) 1.01
Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL. Int Immunopharmacol (2004) 0.91
Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa. J Gastroenterol Hepatol (2005) 0.90
Osteopontin is released from the heart into the coronary circulation in patients with a previous anterior wall myocardial infarction. Circ J (2003) 0.88
Effects of atorvastatin and pravastatin on malondialdehyde-modified LDL in hypercholesterolemic patients. Circ J (2003) 0.87
Real-time PCR assay compared to nested PCR and antigenemia assays for detecting cytomegalovirus reactivation in adult T-cell leukemia-lymphoma patients. J Clin Microbiol (2003) 0.85
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2001)]. Jpn J Antibiot (2003) 0.85
[Pathogenesis of Trichosporon asahii and strategies for infectious control of disseminated trichosporonosis]. Nihon Ishinkin Gakkai Zasshi (2003) 0.85
Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice. FEMS Immunol Med Microbiol (2006) 0.85
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)]. Jpn J Antibiot (2002) 0.84
Evaluation of therapeutic efficacy of adjuvant Helicobacter pylori whole cell sonicate in mice with chronic H. pylori infection. Microbiol Immunol (2002) 0.84
Increased release of glucuronoxylomannan antigen and induced phenotypic changes in Trichosporon asahii by repeated passage in mice. J Med Microbiol (2002) 0.83
Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection, in Japan. Helicobacter (2003) 0.83
Long-term Helicobacter pylori infection in Japanese monkeys induces atrophic gastritis and accumulation of mutations in the p53 tumor suppressor gene. Helicobacter (2002) 0.82
Identification and characterization of a soluble cadherin-7 isoform produced by alternative splicing. J Biol Chem (2002) 0.81
Circulating tenascin-C levels in patients with idiopathic dilated cardiomyopathy. Am J Cardiol (2004) 0.81
Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection. J Gastroenterol (2003) 0.80
Antimicrobial susceptibilities and analysis of genes related to penicillin or macrolide resistance in Streptococcus pneumoniae. Int J Antimicrob Agents (2004) 0.80
Micro-broth dilution method with air-dried microplate for determining MICs of clarithromycin and amoxycillin for Helicobacter pylori isolates. J Med Microbiol (2004) 0.79
Analysis of p53 mutations and Helicobacter pylori infection in human and animal models. J Gastroenterol (2002) 0.79
Spontaneous remission of Epstein-Barr virus-negative non-Hodgkin's lymphoma after withdrawal of cyclosporine in a patient with refractory anemia. Int J Hematol (2004) 0.79
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection. J Gastroenterol Hepatol (2006) 0.78
Intraperitoneal immunization led to T cell hyporesponsiveness to Helicobacter pylori infection in mice. Microbiol Immunol (2002) 0.78
The effect of peritoneal rest in combination therapy of peritoneal dialysis and hemodialysis: using the cultured human peritoneal mesothelial cell model. J Artif Organs (2005) 0.78
The expression of pro- and anti-apoptotic Bcl-2 family proteins in peribronchiolar lymphocytes from patients with diffuse panbronchiolitis. Respir Med (2006) 0.78
Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice. Antimicrob Agents Chemother (2004) 0.78
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2002)]. Jpn J Antibiot (2004) 0.78
Successful induction of long-term remission using rituximab in a patient with refractory hairy cell leukemia-Japanese variant. Int J Hematol (2004) 0.78
Antibiotic-induced apoptosis in human activated peripheral lymphocytes. Int J Antimicrob Agents (2005) 0.78
Clindamycin modulates inflammatory-cytokine induction in lipopolysaccharide-stimulated mouse peritoneal macrophages. Antimicrob Agents Chemother (2003) 0.78
Synergistic cytotoxicity of acidity and 3,4-Dideoxyglucosone-3-ene under the existence of lactate in peritoneal dialysis fluid. Ther Apher Dial (2005) 0.77
Prolonged remission of adult T-cell leukemia/lymphoma treated with interferon-gamma following autologous peripheral blood stem cell transplantation. Leuk Lymphoma (2005) 0.76
Synergistic cytotoxicity of acidity and glucose degradation products in peritoneal dialysis fluid. J Artif Organs (2004) 0.76
Effect of hemodiafiltration against radical stress in the course of blood purification. Blood Purif (2004) 0.76
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2004)]. Jpn J Antibiot (2006) 0.76
Treatment with rokitamycin suppresses the lethality in a murine model of Escherichia coli O157:H7 infection. Int J Antimicrob Agents (2003) 0.76
Significance of neutrophil counts after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Circ J (2005) 0.75
The transcription factor CCAAT-binding factor CBF/NF-Y and two repressors regulate the core promoter of the human pro-alpha3(V) collagen gene (COL5A3). J Biol Chem (2004) 0.75
Evaluation of the Helicobacter pylori stool antigen (HpSA) assay for diagnosing infection and confirming eradication after treatment. J Gastroenterol (2004) 0.75
[A case of adult-onset Still's disease complicated with acute respiratory distress syndrome]. Nihon Kokyuki Gakkai Zasshi (2002) 0.75
Efficacy of long-term macrolide antibiotic therapy in patients with diffuse panbronchiolitis: comparison between HLA-B54-positive and -negative cases. Int J Antimicrob Agents (2004) 0.75
[A case of suspected lung metastasis of pancreatic carcinoma with bronchorrhea similar to bronchioloalveolar carcinoma]. Nihon Kokyuki Gakkai Zasshi (2002) 0.75
[Drug sensitivity test for Helicobacter pylori]. Nihon Rinsho (2002) 0.75
Association of peripheral mononuclear cells containing Chlamydia pneumoniae DNA with acute coronary syndrome and stable coronary artery disease in Japanese subjects. Clin Infect Dis (2004) 0.75
[Management of respiratory infections in lung cancer]. Nihon Rinsho (2002) 0.75
Myeloid/natural killer cell precursor acute leukaemia with minor bcr/abl mRNA transcript. Br J Haematol (2002) 0.75
Effect of preinfarction angina on heart rate variability in the early phase of the first anterior wall acute myocardial infarction. Circ J (2002) 0.75
[Results of survey of adult community-acquired pneumonia utilizing flow chart of diagnostic guideline for management of respiratory infections]. Nihon Kokyuki Gakkai Zasshi (2003) 0.75
[Therapies for intractable respiratory infection due to Pseudomonas aeruginosa]. Nihon Naika Gakkai Zasshi (2005) 0.75
[A case of Pseudomans aeruginosa pneumonia complicated with multiple pustular skin lesions]. Kansenshogaku Zasshi (2002) 0.75
[Effect of macrolide antibiotics on induction of apoptosis in activated lymphocytes]. Jpn J Antibiot (2003) 0.75
[Recent topics on important drugs for H. pylori eradication: Amoxicillin (AMPC)]. Nihon Rinsho (2005) 0.75
[Positioning of various anti-bacterial agents and their appropriate application in the era of multiple bacterial drug resistance. 1. Penicillins]. Nihon Naika Gakkai Zasshi (2003) 0.75
[Proper use of carbapenem antibiotics based on the feature in the treatment of infectious diseases (discussion)]]. Jpn J Antibiot (2004) 0.75
[Clarithromycin (CAM)]. Nihon Rinsho (2002) 0.75
[A case of simple ulcer with ulcerative colitis]. Nihon Shokakibyo Gakkai Zasshi (2005) 0.75
Interferon therapy for hepatitis C virus (HCV)-related advanced chronic hepatitis after treatment of recurrent hepatocellular carcinoma: a successful case. Intern Med (2002) 0.75
[Culture method for H. pylori]. Nihon Rinsho (2003) 0.75
Relationship between heart rate variability and left ventricular remodeling after reperfused first anterior wall acute myocardial infarction. Circ J (2003) 0.75
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2003)]. Jpn J Antibiot (2005) 0.75
[New effects of antimicrobial agents other than antimicrobial activity]. Nihon Rinsho (2003) 0.75
Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial. J Gastroenterol Hepatol (2006) 0.75
[Infectious endocarditis revealed by the rupture of bacterial cerebral aneurysm under the treatment of spondylodicitis]. Nihon Naika Gakkai Zasshi (2005) 0.75
Natural killer cell-type body cavity lymphoma following chronic active Epstein-Barr virus infection. Am J Hematol (2003) 0.75
[Minocycline-containing eradication therapy for patients with clarithromycin-resistant Helicobacter pylori infection]. Nihon Rinsho (2002) 0.75
Response to cyclosporine therapy in patients with myelodysplastic syndrome: a clinical study of 12 cases and literature review. Int J Hematol (2004) 0.75
[Quality control for antimicrobial susceptibility test using correlation between MIC results]. Rinsho Byori (2002) 0.75
[The mechanism of apoptosis induction in lymphocytes by macrolide antibiotics and the related intra-cellular molecular structure]. Jpn J Antibiot (2004) 0.75
[A multicenter study of a new Helicobacter pylori selective medium. Columbia horse blood agar HP]. Kansenshogaku Zasshi (2002) 0.75
[Toward eradication of refractory respiratory infections--Pseudomonas infection of the respiratory system]. Nihon Naika Gakkai Zasshi (2005) 0.75